[Prediction of the development of Alzheimer disease in patients with mild cognitive impairment].

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.3143/GERIATRICS.47.147PMID 20472978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• The pathogenesis of Friedreich ataxia and the structure and function of frataxin

  2009cited by this paper
• Difference in practice effects depending on cerebral perfusion pattern in mild cognitive impairment

  2008cited by this paper
• MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment

  2008cited by this paper
• 老年期認知症患者の病識―生活健忘チェックリストを用い， 介護者を対照とした研究―

  2007cited by this paper
• UNAWARENESS OF MEMORY DEFICITS DEPENDING ON CEREBRAL PERFUSION PATTERN IN MILD COGNITIVE IMPAIRMENT

  2007cited by this paper
• Hippocampal and entorhinal atrophy in mild cognitive impairment

  2007cited by this paper
• [Awareness of memory deficits in patients with dementias: a study with the Everyday Memory Checklist].

  2007cited by this paper
• Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD.

  2006cited by this paper
• Voxel-based morphometry to discriminate early Alzheimer's disease from controls.

  2005cited by this paper
• The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT

  2005cited by this paper
• Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

  2005cited by this paper
• Vitamin E and donepezil for the treatment of mild cognitive impairment.

  2005cited by this paper
• Cerebrospinal fluid tau protein and periventricular white matter lesions in patients with mild cognitive impairment: implications for 2 major pathways.

  2004cited by this paper
• Mild cognitive impairment

  2003cited by this paper
• Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

  2002cited by this paper
• Current concepts in mild cognitive impairment.

  2001cited by this paper
• Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

  1999cited by this paper
• A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

  1995cited by this paper
• Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version.

  1986cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Mental and Physical Self-Awareness of Alzheimer Patients: Decreased Awareness of Amnesia and Increased Fear of Falling Compared to Views of Families: The Tajiri and Wakuya Projects

  2021cites this paper
• Diagnosis of amyloid-positive mild cognitive impairment using structural magnetic resonance imaging: The worth of multiple regions of interest

  2015cites this paper
• Telomere Shortening and Alzheimer’s Disease

  2012cites this paper